WC
PFE icon

Waterloo Capital’s Pfizer PFE Stock Holding History

Waterloo Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Sell
28,858
-5,185
-15% -$136K 0.04% 294
2026
Q1 		$956K Buy
34,043
+7,882
+30% +$210K 0.07% 214
2025
Q4 		$651K Buy
26,161
+1,377
+6% +$34.7K 0.05% 258
2025
Q3 		$632K Buy
24,784
+7,243
+41% +$179K 0.05% 237
2025
Q2 		$425K Buy
17,541
+2,499
+17% +$58.3K 0.03% 299
2025
Q1 		$381K Buy
15,042
+405
+3% +$10.6K 0.04% 288
2024
Q4 		$388K Sell
14,637
-3,930
-21% -$107K 0.04% 265
2024
Q3 		$537K Sell
18,567
-1,665
-8% -$48.6K 0.06% 224
2024
Q2 		$566K Sell
20,232
-41,162
-67% -$1.13M 0.07% 205
2024
Q1 		$1.7M Buy
61,394
+15,046
+32% +$418K 0.22% 103
2023
Q4 		$1.33M Buy
+46,348
New +$1.4M 0.22% 108

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Waterloo Capital's PFE Position: Q2 2026 in Review

Waterloo Capital reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $136K and leaving 28,858 shares worth $695K. The position accounts for 0.04% of the portfolio, ranked #294.

Waterloo Capital first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.7M in Q1 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Waterloo Capital held 28,858 shares of Pfizer worth $695K as of Q2 2026.
  • Waterloo Capital sold 5,185 Pfizer shares in Q2 2026, an estimated $136K.
  • Pfizer made up 0.04% of Waterloo Capital's portfolio in Q2 2026, its #294 holding.
  • Waterloo Capital first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Waterloo Capital's Pfizer position peaked at $1.7M in Q1 2024.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.